Drug Type Interferons, Biosimilar |
Synonyms 莱福隆 |
Target |
Action agonists, stimulants, inducers |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunostimulants, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1999), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Condylomata Acuminata | China | 01 Jan 1999 | |
Hairy Cell Leukemia | China | 01 Jan 1999 | |
Hepatitis B | China | 01 Jan 1999 | |
Hepatitis C | China | 01 Jan 1999 | |
Kaposi Sarcoma | China | 01 Jan 1999 | |
Lymphoma | China | 01 Jan 1999 | |
Melanoma | China | 01 Jan 1999 | |
Philadelphia chromosome positive chronic myelogenous leukemia | China | 01 Jan 1999 |